SUBSCRIBE
SUBSCRIBE

BioSpace Insights

The BioSpace Insights team performs research and analysis on industry trends for BioSpace and clients, producing industry reports, podcasts, events and articles.

IN PARTNERSHIP WITH ECLIPSEBIO
Why Countries Are Racing To Build mRNA Factories While America Hesitates on Next-Gen Vaccines
In this episode presented by Eclipsebio, BioSpace’s head of insights Lori Ellis continues the discussion on mRNA and srRNA with Andy Geall of Replicate Bioscience and Alliance for mRNA Medicines and Pad Chivukula of Arcturus Therapeutics.
July 22, 2025
 · 
1 min read
 · 
Lori Ellis
Job Trends
Report: U.S. Life Sciences Job Market Report Q2 2025
The life sciences job market continues to shift. BioSpace’s Q2 2025 U.S. Life Sciences Job Market Report is now available, offering exclusive insights into the latest hiring trends, layoffs, and workforce dynamics across the life sciences industry.
July 17, 2025
 · 
1 min read
 · 
BioSpace Insights
IN PARTNERSHIP WITH IQVIA
AI Is Taking Over Drug Safety Monitoring–But There’s One Thing It Can’t Replace
In this episode presented by IQVIA, BioSpace’s head of insights Lori Ellis discusses the evolving role of local qualified persons for pharmacovigilance with ⁠Ana Pedro Jesuíno⁠, global head local QPPV network at IQVIA.
July 17, 2025
 · 
1 min read
 · 
Lori Ellis
IN PARTNERSHIP WITH EVOTEC
Webinar: Pharma Industry in Crisis
With venture funding tightening in the post-COVID landscape, efficiency has become more critical than ever. In this interactive webinar industry experts explored actionable strategies for maintaining quality under financial pressure. Watch now.
July 16, 2025
 · 
1 min read
 · 
BioSpace Insights
World Management Team in office silhouette 3d rendering
Drug Development
The Gap Between the Administration’s Pro-Innovation Words and Policy
Despite the FDA commissioner’s promises of partnership and collaboration, personnel changes and continued federal cuts create uncertainty for an industry already struggling with nearly half a decade of investment scarcity.

July 14, 2025
 · 
6 min read
 · 
Lori Ellis
IN PARTNERSHIP WITH ECLIPSEBIO
The mRNA Revolution You Haven’t Heard About: From Cystic Fibrosis to Personalized Cancer Vaccines
In this episode presented by Eclipsebio, BioSpace’s head of insights Lori Ellis discusses mRNA and srRNA with Andy Geall of Replicate Bioscience and Alliance for mRNA Medicines, and Pad Chivukula of Arcturus Therapeutics.
July 10, 2025
 · 
1 min read
 · 
Lori Ellis
IN PARTNERSHIP WITH IQVIA
Understanding the FDA’s AI Guidance in Pharmacovigilance
In this episode presented by IQVIA, BioSpace’s head of insights Lori Ellis discusses the FDA’s first draft guidance for AI in drug development, published in January 2025, with Archana Hegde, senior director, pv systems and innovations at IQVIA.
July 1, 2025
 · 
1 min read
 · 
Lori Ellis
IN PARTNERSHIP WITH PATSNAP
Webinar: Beyond Theory: Real-World AI Wins in Life Science R&D, Faster & Smarter
Are long R&D cycles, overwhelming literature reviews, or patent bottlenecks slowing your path to innovation? In the fast-evolving life science landscape, AI is no longer a luxury, it’s a necessity.
June 25, 2025
 · 
1 min read
 · 
BioSpace Insights
Business
Navigating Funding Freezes and AI Frontiers
In this episode of Denatured, BioSpace’s Head of Insights Lori Ellis discusses key themes from BIO and DIA, including the funding environment, with Rich Daly, CEO of Catalyst Pharmaceuticals, Peter Ronco, CEO of Emmes Corporation, and Phil Vanek, founder of Redline Bio Advisors.
June 20, 2025
 · 
1 min read
 · 
Lori Ellis
IN PARTNERSHIP WITH IQVIA
AI’s Role in Decoding the FDA’s New Regulatory Communications
In this episode of Denatured, presented by IQVIA, BioSpace’s head of insights Lori Ellis discusses how AI transformation can help organizations navigate a rapidly evolving regulatory environment with senior director of regulatory innovation and technology, Michelle Gyzen.
June 5, 2025
 · 
1 min read
 · 
Lori Ellis
IN PARTNERSHIP WITH IQVIA
How Target Product Profiles Guide the Industry Through Uncertain Times
In this episode presented by IQVIA, BioSpace’s head of insights Lori Ellis discusses the importance of target product profiles, particularly when navigating funding challenges, with Ian Fisher, head of development analytics.
May 22, 2025
 · 
1 min read
 · 
Lori Ellis
BROUGHT TO YOU BY PLIANCY
Webinar: Are We There Yet? Surviving and Thriving in the Never-ending Biotech Downturn
BioSpace sits down with four NextGen companies that are thriving despite a multi-year down period. You will hear about ways they are defying the odds to churn out clinical data that may finally provide the industry with a ladder out. Watch now.
May 21, 2025
 · 
1 min read
 · 
BioSpace Insights
istock/ArtemisDiana
PARTNERED
Where AI Adds Real Value in Clinical Development
While Quantum computing has been reported to be five years away for many years now, companies are preparing for it by setting foundations with AI in development.
May 12, 2025
 · 
7 min read
 · 
BioSpace Insights
Drug Development
Eroding Immunity: Vaccine Hesitancy and Cynicism With Paul Offit
In this episode of Denatured BioSpace’s head of insights Lori Ellis discusses the public health consequences of vaccine hesitancy and the critical distinction between skepticism and cynicism with Paul Offit, MD, director of the Vaccine Education Center at the Children’s Hospital of Philadelphia.
May 8, 2025
 · 
1 min read
 · 
Lori Ellis
IN PARTNERSHIP WITH DIA
Economic Challenges, Strategic Investments: Reshaping the Women’s Health Landscape
In this episode presented by DIA, BioSpace’s head of insights Lori Ellis discusses how collaboration and investment shape the the future of women’s health with Martin Hodosi, partner at Kearney and Melissa Laitner, director of strategic initiatives at the National Academy of Medicine.
April 24, 2025
 · 
1 min read
 · 
Lori Ellis
Load More